Nikhil I. Khushalani, MD, is the vice chair for the Department of Cutaneous Oncology at Moffitt Cancer Center. His clinical interests include the development of novel therapeutics for people diagnosed with melanoma and other skin cancers, the treatment of uveal melanoma, and melanoma that has metastasized to the brain. Dr. Khushalani’s research interests focus on angiogenesis in melanoma and the translation of findings into clinical therapeutics. He is studying the economic impact of new melanoma drugs on healthcare (pharmacoeconomics) with an aim to devise strategies for cost reduction. Prior to joining the Moffitt team, he served as associate professor of medicine at the State University of New York (SUNY) at Buffalo, where he was the section chief of soft tissue and melanoma medicine, and director of the IL-2 program.
Dr. Khushalani earned his medical degree from Topiwala National Medical College, University of Mumbai (formerly Bombay) in Maharashtra, India, and his internal medicine residency at SUNY Buffalo, where he also served as chief resident. He completed a medical oncology fellowship at Roswell Park Comprehensive Cancer Center in 2002, where he served as assistant professor of oncology.